Live feed17:00:00·1435dPRReleasevia QuantisnowDSS Announces Licensing of Impact BioMedical's Linebacker Portfolio to ProPhase LabsByQuantisnow·Wall Street's wire, on your screen.DSS· DSS Inc.PRPH· ProPhase Labs Inc.Consumer DiscretionaryHealth Care